What LL-37 is
Human cathelicidin antimicrobial peptide studied in innate immunity, infection biology, inflammation and wound healing. It is also referred to as Cathelicidin LL-37.
How it works
Disrupts microbial membranes and modulates immune, angiogenic and epithelial-repair pathways.
What the evidence shows
Strong basic science; insufficient evidence for routine therapeutic administration.
Evidence level: D/E — Preclinical to experimental human use.
Routes studied: Experimental.
Doses studied: Research write-ups list research dosing, but there is no FDA-approved or evidence-based routine human regimen.
What this page does not claim
LL-37 is not a treatment for Lyme disease, MRSA or chronic infection.
Safety considerations
Exogenous dosing could provoke inflammatory or immune effects; human safety is not established.
- Cautions and contraindications: Autoimmune/inflammatory context requires caution.
- Possible interactions: Immunomodulators.
Sport and anti-doping
Unknown.
Availability at True Heal Wellness
True Heal Wellness does not offer, sell or administer LL-37. This page exists as an educational reference only.